Journal article
The role of radioactive iodine in the treatment of well-differentiated thyroid cancer
Surgical oncology clinics of North America, Vol.15(3), pp.625-638
07/2006
DOI: 10.1016/j.soc.2006.05.007
PMID: 16882501
Abstract
The prognosis in differentiated thyroid cancer is excellent. The completeness of thyroidectomy and removal of involved regional metastases are the most important elements of management. Iodine 131 has a role in ablating residual thyroid and treating regional and distant metastases. The effectiveness of the treatment is confirmed by negative follow-up scans and low or undetectable Tg. This therapy is relatively specific, but other tissues can receive meaningful doses of radiation and acute and long-term complications can occur. Therefore, whether the patient will have a better prognosis after treatment with 131I and whether the benefits of treatment are greater than the side effects must be determined for every patient.
Details
- Title: Subtitle
- The role of radioactive iodine in the treatment of well-differentiated thyroid cancer
- Creators
- Ronald J Weigel - Roy J. and Lucille A. Carver College of MedicineI Ross McDougall - Stanford University
- Resource Type
- Journal article
- Publication Details
- Surgical oncology clinics of North America, Vol.15(3), pp.625-638
- DOI
- 10.1016/j.soc.2006.05.007
- PMID
- 16882501
- ISSN
- 1055-3207
- eISSN
- 1558-5042
- Language
- English
- Date published
- 07/2006
- Academic Unit
- Molecular Physiology and Biophysics; Anatomy and Cell Biology; Surgery; Biochemistry and Molecular Biology
- Record Identifier
- 9984284340402771
Metrics
16 Record Views